Breaking News Instant updates and real-time market news.

OTIS

Otis Worldwide

$71.23 /

-0.185 (-0.26%)

06:40
07/07/22
07/07
06:40
07/07/22
06:40

Otis Worldwide downgraded to Neutral from Overweight at JPMorgan

JPMorgan analyst Stephen Tusa downgraded Otis Worldwide to Neutral from Overweight with a $62 price target.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Acadia Pharmaceuticals price target lowered to $21 from $26 at RBC Capital » 06:54
08/09/22
08/09
06:54
08/09/22
06:54
ACAD

Acadia Pharmaceuticals

$16.65 /

+0.225 (+1.37%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

06:36 Today Mizuho
Acadia Pharmaceuticals price target lowered to $19 from $27 at Mizuho
06:23 Today H.C. Wainwright
Acadia Pharmaceuticals price target raised to $25 from $20 at H.C. Wainwright
05:40 Today Citi
Acadia Pharmaceuticals price target raised to $17 from $15 at Citi
08/08/22 Cowen
Acadia Pharmaceuticals price target lowered to $21 from $32 at Cowen
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

Earnings
ChannelAdvisor sees FY22 revenue $177M-$179M, consensus $177.99M  06:54
08/09/22
08/09
06:54
08/09/22
06:54
ECOM

ChannelAdvisor

$15.49 /

+0.53 (+3.54%)

 
ShowHide Related Items >><<
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

06/29/22 B. Riley
ChannelAdvisor risk/reward skews to the upside, says B. Riley
05/09/22 B. Riley
ChannelAdvisor price target lowered to $24 from $32 at B. Riley
02/11/22 Needham
ChannelAdvisor price target lowered to $26 from $35 at Needham
02/02/22 B. Riley
ChannelAdvisor price target lowered to $32 from $38 at B. Riley
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

Recommendations
Palantir price target lowered to $11 from $13 at Morgan Stanley » 06:54
08/09/22
08/09
06:54
08/09/22
06:54
PLTR

Palantir

$9.82 /

-1.625 (-14.20%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

05:38 Today Citi
Palantir price target lowered to $6 from $7 at Citi
05:18 Today Deutsche Bank
Palantir downgraded to Sell from Hold at Deutsche Bank
08/08/22 Jefferies
Palantir price target lowered to $12 from $13 at Jefferies
08/03/22 RBC Capital
U.S. federal spending tracker 'worrisome' for Palantir, says RBC Capital
PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

Earnings
IAA sees FY22 revenue $2.020B-$2.075B, consensus $2.1B » 06:54
08/09/22
08/09
06:54
08/09/22
06:54
IAA

IAA

$38.26 /

+0.54 (+1.43%)

FY22 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAA IAA
$38.26 /

+0.54 (+1.43%)

IAA IAA
$38.26 /

+0.54 (+1.43%)

06/09/22 Guggenheim
IAA upgraded to Buy from Neutral at Guggenheim
05/10/22 Barrington
IAA upgraded to Outperform at Barrington after better-than-expected Q1
05/10/22 Barrington
IAA upgraded to Outperform from Market Perform at Barrington
03/15/22 Stephens
Stephens agrees with activist that IAA undervalued
IAA IAA
$38.26 /

+0.54 (+1.43%)

Earnings
ChannelAdvisor sees Q3 revenue $43.4M-$43.8M, consensus $44.28M  06:54
08/09/22
08/09
06:54
08/09/22
06:54
ECOM

ChannelAdvisor

$15.49 /

+0.53 (+3.54%)

 
ShowHide Related Items >><<
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

06/29/22 B. Riley
ChannelAdvisor risk/reward skews to the upside, says B. Riley
05/09/22 B. Riley
ChannelAdvisor price target lowered to $24 from $32 at B. Riley
02/11/22 Needham
ChannelAdvisor price target lowered to $26 from $35 at Needham
02/02/22 B. Riley
ChannelAdvisor price target lowered to $32 from $38 at B. Riley
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

Hot Stocks
Signet Jewelers to acquire Blue Nile for $360M in cash, sees accretion in FY24 » 06:54
08/09/22
08/09
06:54
08/09/22
06:54
SIG

Signet Jewelers

$67.78 /

+4.135 (+6.50%)

Signet Jewelers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

06/10/22 UBS
Signet Jewelers price target lowered to $120 from $138 at UBS
06/10/22 Citi
Signet Jewelers price target lowered to $76 from $94 at Citi
04/05/22 Wells Fargo
Signet Jewelers price target lowered to $105 from $140 at Wells Fargo
03/18/22 Citi
Signet Jewelers price target raised to $94 from $90 at Citi
SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

Recommendations
uniQure price target lowered to $24 from $34 at Wells Fargo » 06:53
08/09/22
08/09
06:53
08/09/22
06:53
QURE

uniQure

$18.60 /

-6.92 (-27.12%)

Wells Fargo analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$18.60 /

-6.92 (-27.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

06:21 Today H.C. Wainwright
uniQure selloff brings attractive entry point, says H.C. Wainwright
08/08/22 Chardan
uniQure price target lowered to $60 from $65 at Chardan
08/08/22 Truist
uniQure's high-dose HD data still on track for 1H23, says Truist
05/05/22 Stifel
uniQure price target lowered to $37 from $66 at Stifel
QURE uniQure
$18.60 /

-6.92 (-27.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

Earnings
ChannelAdvisor reports Q2 EPS 6c, consensus 15c » 06:53
08/09/22
08/09
06:53
08/09/22
06:53
ECOM

ChannelAdvisor

$15.49 /

+0.53 (+3.54%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

06/29/22 B. Riley
ChannelAdvisor risk/reward skews to the upside, says B. Riley
05/09/22 B. Riley
ChannelAdvisor price target lowered to $24 from $32 at B. Riley
02/11/22 Needham
ChannelAdvisor price target lowered to $26 from $35 at Needham
02/02/22 B. Riley
ChannelAdvisor price target lowered to $32 from $38 at B. Riley
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

Recommendations
Accenture price target raised to $338 from $310 at Baird » 06:52
08/09/22
08/09
06:52
08/09/22
06:52
ACN

Accenture

$310.24 /

+0.915 (+0.30%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$310.24 /

+0.915 (+0.30%)

ACN Accenture
$310.24 /

+0.915 (+0.30%)

07/18/22 Piper Sandler
Accenture price target lowered to $281 from $305 at Piper Sandler
06/29/22 Exane BNP Paribas
Accenture downgraded to Neutral from Outperform at Exane BNP Paribas
06/25/22 Barclays
Accenture price target lowered to $370 from $455 at Barclays
06/24/22 RBC Capital
Accenture price target lowered to $357 from $435 at RBC Capital
ACN Accenture
$310.24 /

+0.915 (+0.30%)

ACN Accenture
$310.24 /

+0.915 (+0.30%)

ACN Accenture
$310.24 /

+0.915 (+0.30%)

Recommendations
ShockWave Medical price target raised to $255 from $176 at Wells Fargo » 06:52
08/09/22
08/09
06:52
08/09/22
06:52
SWAV

ShockWave Medical

$221.92 /

-0.94 (-0.42%)

Wells Fargo analyst Larry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

04:53 Today Piper Sandler
ShockWave Medical price target raised to $278 from $245 at Piper Sandler
05/23/22 Piper Sandler
ShockWave Medical's China approval adds growth driver, says Piper Sandler
05/10/22 Canaccord
ShockWave Medical price target lowered to $190 from $221 at Canaccord
05/10/22 Wells Fargo
ShockWave Medical price target lowered to $176 from $235 at Wells Fargo
SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

Hot Stocks
Moderna amends Covid-19 vaccine agreement with EC » 06:52
08/09/22
08/09
06:52
08/09/22
06:52
MRNA

Moderna

$183.08 /

-3.71 (-1.99%)

Moderna announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

06/29/22 Evercore ISI
Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
06/14/22 Piper Sandler
Piper Sandler confident in positive VRBPAC opinion for Moderna's SpikeVax
06/13/22 Morgan Stanley
Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
05/17/22 Piper Sandler
Moderna price target lowered to $214 from $348 at Piper Sandler
MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

Earnings
International Seaways reports Q2 adjusted EPS $1.43, consensus $1.19 » 06:51
08/09/22
08/09
06:51
08/09/22
06:51
INSW

International Seaways

$25.40 /

+0.61 (+2.46%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INSW International Seaways
$25.40 /

+0.61 (+2.46%)

INSW International Seaways
$25.40 /

+0.61 (+2.46%)

07/27/22 BTIG
International Seaways upgraded to Buy from Neutral at BTIG
07/20/22 Jefferies
International Seaways initiated with a Buy at Jefferies
07/19/22 Stifel
International Seaways price target raised to $31 from $27 at Stifel
07/06/22 B. Riley
Tanker stocks have more room to run, says B. Riley
INSW International Seaways
$25.40 /

+0.61 (+2.46%)

INSW International Seaways
$25.40 /

+0.61 (+2.46%)

Downgrade
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo » 06:50
08/09/22
08/09
06:50
08/09/22
06:50
GBT

Global Blood Therapeutics

$66.58 /

+2.77 (+4.34%)

, PFE

Pfizer

$49.55 /

+0.29 (+0.59%)

Wells Fargo analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 RBC Capital
Global Blood downgraded to Sector Perform from Outperform at RBC Capital
08/08/22 Cowen
Global Blood Therapeutics downgraded to Market Perform from Outperform at Cowen
08/08/22 Guggenheim
Global Blood Therapeutics downgraded to Neutral from Buy at Guggenheim
PFE Pfizer
$49.55 /

+0.29 (+0.59%)

08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 Oppenheimer
Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer
08/08/22 Stifel
Global Blood Therapeutics downgraded to Hold from Buy at Stifel
08/08/22 Piper Sandler
Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler
GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

Earnings
IAA reports Q2 adjusted EPS 62c, consensus 57c » 06:50
08/09/22
08/09
06:50
08/09/22
06:50
IAA

IAA

$38.26 /

+0.54 (+1.43%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAA IAA
$38.26 /

+0.54 (+1.43%)

IAA IAA
$38.26 /

+0.54 (+1.43%)

06/09/22 Guggenheim
IAA upgraded to Buy from Neutral at Guggenheim
05/10/22 Barrington
IAA upgraded to Outperform at Barrington after better-than-expected Q1
05/10/22 Barrington
IAA upgraded to Outperform from Market Perform at Barrington
03/15/22 Stephens
Stephens agrees with activist that IAA undervalued
IAA IAA
$38.26 /

+0.54 (+1.43%)

Earnings
Target Hospitality reports Q2 EPS 24c, consensus 17c » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TH

Target Hospitality

$13.97 /

+0.12 (+0.87%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

07/12/22 Oppenheimer
Target Hospitality price target raised to $18 from $9 at Oppenheimer
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

Recommendations
Enanta price target raised to $137 from $103 at JMP Securities » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
ENTA

Enanta

$71.21 /

+0.39 (+0.55%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

ENTA Enanta
$71.21 /

+0.39 (+0.55%)

08/01/22 Oppenheimer
Enanta price target raised to $53 from $45 at Oppenheimer
07/29/22 Piper Sandler
Enanta's 'strong' EDP-235 data supports 'impressive' profile, says Piper Sandler
07/06/22 Evercore ISI
Enanta upgraded to Outperform at Evercore ISI ahead of COVID anti-viral data
07/06/22 Evercore ISI
Enanta upgraded to Outperform from In Line at Evercore ISI
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

ENTA Enanta
$71.21 /

+0.39 (+0.55%)

Earnings
Capri Holdings sees FY23 EPS $6.85, consensus $6.74 » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Sees FY23 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

Recommendations
Tyson Foods price target lowered to $95 from $100 at Stephens » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TSN

Tyson Foods

$80.10 /

-7.395 (-8.45%)

Stephens analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

06:16 Today BMO Capital
Tyson Foods price target lowered to $90 from $99 at BMO Capital
05:55 Today Barclays
Tyson Foods price target lowered to $89 from $100 at Barclays
04:57 Today Piper Sandler
Piper upgrades Tyson Foods to Neutral with risks priced in
08/08/22 Piper Sandler
Tyson Foods upgraded to Neutral from Underweight at Piper Sandler
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

Recommendations
Reata Pharmaceuticals price target lowered to $27 from $37 at Baird » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
RETA

Reata Pharmaceuticals

$24.02 /

-11.895 (-33.12%)

Baird analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/08/22 Goldman Sachs
Reata sinks on Friedreich's ataxia update but Goldman remains positive
08/08/22 Goldman Sachs
Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs
05/27/22 Citi
Reata Pharmaceuticals price target raised to $46 from $43 at Citi
05/11/22 Ladenburg
Reata Pharmaceuticals price target lowered to $67 from $75 at Ladenburg
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

Hot Stocks
Wireless Telecom sees Q3 bookings $8M-$10M » 06:48
08/09/22
08/09
06:48
08/09/22
06:48
WTT

Wireless Telecom

$1.56 /

+0.08 (+5.41%)

Tim Whelan, CEO of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

Earnings
Capri Holdings reports Q1 adjusted EPS $1.50, consensus $1.36 » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

Hot Stocks
Planet Fitness announces Jamie Medeiros as chief brand officer » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
PLNT

Planet Fitness

$81.08 /

+0.71 (+0.88%)

Planet Fitness announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22 Exane BNP Paribas
Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
06/07/22 Cowen
Planet Fitness positioned to succeed despite macro challenges, says Cowen
05/25/22 Cowen
Planet Fitness operating model remains resilient among headwinds, says Cowen
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

Recommendations
Mersana Therapeutics price target raised to $20 from $18 at Baird » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
MRSN

Mersana Therapeutics

$5.24 /

+0.215 (+4.28%)

, GSK

GSK plc

$40.31 /

-0.27 (-0.67%)

Baird analyst Collen Kusy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

05/10/22 Baird
Mersana Therapeutics price target lowered to $18 from $23 at Baird
05/09/22 H.C. Wainwright
Mersana price target lowered to $19 from $24 at H.C. Wainwright
11/10/21 Baird
Mersana Therapeutics price target lowered to $23 from $30 at Baird
10/14/21 BTIG
Mersana Therapeutics assumed with a Buy at BTIG
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
08/05/22 Morgan Stanley
GSK plc resumed with an Equal Weight at Morgan Stanley
07/21/22 Citi
GSK plc resumed with a Neutral at Citi
07/20/22 UBS
GSK plc price target lowered to 1,850 GBp from 1,876 GBp at UBS
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

Earnings
Wireless Telecom reports Q2 cont ops EPS (6c), consensus (4c) » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
WTT

Wireless Telecom

$1.56 /

+0.08 (+5.41%)

Reports Q2 revenue $6.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

Recommendations
Scholar Rock price target lowered to $43 from $55 at BMO Capital » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
SRRK

Scholar Rock

$8.54 /

+0.035 (+0.41%)

BMO Capital analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

07/12/22 Truist
Scholar Rock initiated with a Buy at Truist
06/23/22 Piper Sandler
Scholar Rock price target lowered to $19 from $28 at Piper Sandler
05/24/22 JPMorgan
Scholar Rock price target lowered to $37 from $46 at JPMorgan
05/17/22 BMO Capital
Scholar Rock price target lowered to $55 from $74 at BMO Capital
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.